NL-OMON28839尚未招募不适用
The clinical relevance of axillary reverse mapping: A multicenter randomised controlled trial.
none0 个研究点目标入组 280 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 280
研究概览
简要总结
Gobardhan PD, Wijsman JH, van Dalen T, Klompenhouwer EG, van der Schelling GP, Los J, et al. ARM: axillary reverse mapping - The need for selection of patients. Eur J Surg Oncol. 2012 May 17, Epub ahead of print.
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Female patient aged 18 years and over presenting in one of the participating hospitals with the diagnosis invasive breast cancer and an indication for a complementary ALND based on a positive SLN are eligible for an ALND-ARM procedure. The indication for a complementary ALND will be made in a multidisciplinary team including an oncologic surgeon, medical oncologist, pathologist, radiologist and a radiotherapist.
排除标准
- •Primary ALND based on a clinical positive axilla, a contra-indication for SLNB, a history of (breast) cancer, an adverse event during the previous SLNB and pregnancy will be excluded from participation of the RCT.
研究者
相似试验
已完成
不适用
The clinical relevance of axillary reverse mapping (ARM)lymfedemaswelling1002765610006295NL-OMON39541Amphia Ziekenhuis280
已完成
1 期
Axillary Reverse Mapping for Invasive Carcinoma of the BreastBreast CancerNCT00645541M.D. Anderson Cancer Center35
已完成
不适用
Axillary Reverse Mapping in Breast CancerLymph Node Cancer MetastaticNCT05040685Hospital Universitari de Bellvitge43
撤回
不适用
Reverse Axillary Mapping in Breast Radiation Treatment PlanningLymphedemaBreast CancerNCT04292860UNC Lineberger Comprehensive Cancer Center
进行中（未招募）
3 期
Axillary Reverse Mapping in Preventing Lymphedema in Patients With Breast Cancer Undergoing Axillary Lymph Node DissectionBreast Cancer Stage IBreast Cancer Stage IIBreast Cancer Stage IIINCT03927027Alliance for Clinical Trials in Oncology534